Lead EvaluAtion for Defibrillation and Reliability (LEADR)
Recruiting
18 years - 99 years
All
500 participants needed
1 Location
Brief description of study
The research study is being conducted to assess the safety and efficacy of Medtronic’s Next Generation ICD lead.
Duration 18 to 36 months.
Detailed description of study
The research study is being conducted to assess the safety and efficacy of Medtronic’s Next Generation ICD lead.
Duration 18 to 36 months.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Heart, Cardiac, Defibrillation
-
Age: 18 years - 99 years
-
Gender: All
Adults diagnosed with heart disease whose doctor recommends implant of an ICD or CRT-D device.
Updated on
04 Aug 2024.
Study ID: 850232
Find a site
,
Your Information has been sent successfully.
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or